Balaxi Pharmaceuticals consolidated net profit rises 19.07% in the September 2021 quarter
Sales rise 16.41% to Rs 70.23 crore
Net profit of Balaxi Pharmaceuticals rose 19.07% to Rs 12.05 crore in the quarter ended September 2021 as against Rs 10.12 crore during the previous quarter ended September 2020. Sales rose 16.41% to Rs 70.23 crore in the quarter ended September 2021 as against Rs 60.33 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales70.2360.33 16 OPM %19.9817.07 -PBDT14.1511.88 19 PBT14.0311.81 19 NP12.0510.12 19Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 28 2021 | 2:20 PM IST